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Van Herzeele I., Aggarwal R., Malik I., Gaines P., Hamady M., Darzi A.,
Cheshire N., Vermassen F., (European Virtual Reality Endovascular Re-
search Team EVEResT). Eur J Vasc Endovasc Surg 2009;38:1-9.
Objectives: To develop weighted error-based, generic and procedure-
specific rating scales, to validate these scales for video-based assessment
during virtual carotid artery stent (CAS) procedures and correlate them with
simulator-derived metrics.
Methods: A questionnaire was developed to assess the technique
during live CAS procedures. Errors were rated from 1 (unimportant) to 5
(life-threatening) by 28 highly experienced CAS (50 CAS) physicians.
Virtual CAS procedure was performed by 21 interventionalists with varied
CAS experience. Fluoroscopy screen and hand movements were video-
taped, and simulator-derived metrics recorded. Experienced CAS practi-
tioners then rated the video-taped performances using weighted error,
generic and procedure-specific rating scales.
Results: Of the 23 errors assessed, 12 were regarded as moderate (score
3), six serious (score 4) and four life-threatening (score 5). The generic rating
scale was able to detect significant differences in performance between inexpe-
rienced and experiencedCASoperators (score 25 vs.32 respectively,P 0.01).
All scoring systems demonstrated good inter-rater reliability (  0.61–0.87).
Significant correlations were observed between simulator-derived and video-
based scores: weighted error-based score (r: 0.76, P 0.01), generic (r: 0.62,
P 0.01) and procedure-specific (r: 0.76, P 0.01) rating scales.
Conclusions: The generic endovascular rating scale differentiated be-
tween levels of CAS experience among skilled interventionalists and corre-
lated to simulator-based error scoring.
Extracranial and Transcranial Ultrasound Assessment in Patients with
Suspected Positional ‘Vertebrobasilar Ischaemia’
Sultan M.J., Hartshorne T., Naylor A.R. Eur J Vasc Endovasc Surg 2009;
38:10-13.
Objectives: A diagnosis of ‘positional’ vertebrobasilar ischaemia is
considered in patients presenting with dizziness/vertigo during lateral
neck rotation/extension and is attributed to bony ‘nipping’ of the
vertebral artery (VA). This study reviewed our experience with extracra-
nial and transcranial ultrasound to determine whether a diagnosis of
‘positional’ vertebrobasilar ischaemia was associated with any changes in
flow in the extracranial VA and the P1 segment of the posterior cerebral
artery (PCA) during head turning.
Methods: A retrospective case note review was undertaken in 46
patients with an accessible window for transcranial Doppler who had under-
gone extracranial and transcranial assessment of flow velocity and flow
directionality in the VA and PCA while the head was moved into positions
that normally triggered the patient’s symptoms.
Results: Positional ‘vertebrobasilar symptoms’ were triggered by lat-
eral head rotation in 35 patients (76%), while 11 (24%) developed symptoms
following neck extension. Only one patient was found to have a significant
carotid stenosis (symptoms unchanged following carotid endarterectomy)
and none had significant disease in the extracranial VAs. None of the patients
exhibited any change in extracranial VA flow during head turning/extension
and none had reversal of flow either. Similarly, there was no change observed
in the PCA flow characteristics during head turning. Themajority of patients
(74%) were subsequently referred to the Ear, Nose and Throat (ENT)
department, and 94% of the patients noted an improvement in symptoms
following entry into a vestibular rehabilitation programme.
Conclusions: A diagnosis of ‘positional’ vertebrobasilar ischaemia
should bemade with extreme caution and only after a specialist assessment in
a Balance Centre.
Modern Treatment of Juxtarenal Abdominal Aortic Aneurysms with
Fenestrated Endografting and Open Repair – A Systematic Review
Nordon I.M., Hinchliffe R.J., Holt P.J., Loftus I.M., Thompson M.M. Eur
J Vasc Endovasc Surg 2009;38:35-41.
Introduction: Advances in endovascular technology have led to the
introduction of fenestrated stents to treat juxtarenal aneurysms (JRAs),
previously deemed unsuitable for standard endovascular repair (EVR). This
article reviews the outcomes of fenestrated technology and makes a compar-
ison with open repair.
236Methods: A systematic review of the literature was performed.
Results: No randomised studies were identified. 8 cohort studies
reporting 368 f-EVR cases and 12 cohorts reporting 1164 open repairs of
JRAs were identified. Analysis of outcome measures found the f-EVR and
open cohorts to be homogeneous. Combining studies identified an in-
creased 30-day mortality after open repair when compared to f-EVR (Rela-
tive risk (RR) 1.03, 95% Confidence interval (CI) 1.01–1.04, p  .02), 2%
increased absolute mortality. No difference was identified in postoperative
permanent dialysis dependence (RR 1.00, CI 0.99–1.01, p  1). Transient
renal failure was more common following open repair (RR 1.06, CI 1.01–
1.12, p  .03). Early re-interventions were less common following open
repair (RR 0.87, CI 0.83–0.91, p  .0001).
Conclusions: Selective f-EVR appears to have reduced peri-operative
mortality compared with traditional open surgery, yet selectivity within the
study groups and lack of a rigorous classification prohibit more robust
comparison. Promising short-term results confirm a role for f-EVR in
management of complex abdominal aneurysms.
Oversizing of Aortic Stent Grafts for Abdominal Aneurysm Repair: A
Systematic Review of the Benefits and Risks
van Prehn J., Schlösser F.J.V., Muhs B.E., Verhagen H.J.M., Moll F.L., van
Herwaarden J.A. Eur J Vasc Endovasc Surg 2009;38:42-53.
Objective: Sizing of aortic endografts is an essential step in successful
endovascular treatment of aortic pathology, although consensus regarding
the optimal sizing strategy is lacking. Some proximal oversizing is necessary
to obtain a seal between the stent graft and the aortic wall and to prevent the
graft from migrating, but excessive oversizing might influence the results
negatively. In this systematic review, we investigated the current literature to
obtain an overview of the risks and benefits of oversizing and to determine
the optimal degree of oversizing of stent grafts used for endovascular
abdominal aortic aneurysm repair.
Methods: PUBMED, EMBASE and Cochrane Library databases were
searched for articles related to the impact of proximal endograft oversizing
on complications after endovascular aneurysm repair. After in- and exclu-
sion, 23 relevant articles reporting on 8415 patients remained for analysis
and critical appraisal.
Results: Most studies that investigated neck dilatation are flawed by
poor methodology. No clear relationship between proximal oversizing and
neck dilatation relative to the first post-operative scan was found. None of
the studies described a positive relationship between the degree of oversizing
and the incidence of endoleaks. On the contrary, oversizing up to 25% seems
to decrease the risk of proximal endoleaks. There are conflicting data
regarding the risk of graft migration when oversizing by more than 30%.
Conclusions: Based on the best available evidence, the current stan-
dard of 10–20% oversizing regime appears to be relatively safe and prefera-
ble. Oversizing 30% might negatively impact the outcome after EVAR.
Studies of higher quality are needed to further assess the relationship
between proximal oversizing and the incidence of complications, particularly
regarding the impact on aneurysm neck dilatation.
Management of Limb Ischaemia in the Neonate and Infant
Arshad A., McCarthy M.J. Eur J Vasc Endovasc Surg 2009;38:61-65.
Aim: This article aims to provide the reader with an insight into the
diagnosis and management of limb ischaemia presenting in neonates and
infants by examining the published literature.
Materials and methods: A Pubmed search and an Ovid Medline/
Embase search were both performed. The keywords were: ‘neonatal’ or ‘paedi-
atric’ or ‘pediatric’ and ‘limb’ and ‘ischemia’ or ‘ischaemia’ and relevant articles
were retrieved and analysed. Articles pertaining to children over the age of
3 years and non-English literature articles were excluded.
Selective and Sustained Delivery of Basic Fibroblast Growth Factor
(bFGF) for Treatment of Peripheral Arterial Disease: Results of a Phase
I Trial
Hashimoto T., Koyama H., Miyata T., Hosaka A., Tabata Y., Takato T.,
Nagawa H. Eur J Vasc Endovasc Surg 2009;38:71-75.Objectives: The aim of this study was to evaluate the safety of selective
and sustained delivery of basic fibroblast growth factor (bFGF) using acidic
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arterial disease (PAD).
Materials and methods:We conducted a non-randomised and uncon-
trolled trial involving prospective observation of eight patients (eight limbs)
with PAD — five limbs with arteriosclerosis obliterans and three limbs with
thromboangiitis obliterans, five limbs (three arms and two legs) with critical
limb ischaemia (CLI) and three limbs with intermittent claudication (IC)—
who were followed up for 6 months or more. AGHM suspension containing
100 g bFGF was infused into the artery of the affected limb. Besides
evaluation of safety and changes in symptoms, resting ankle–brachial pres-
sure index measurement and transcutaneous PO2 (tcPO2), angiography
were conducted at baseline and then at various time points. Skin perfusion
pressure as an index of CLI and claudication distance as an index of IC were
also used to assess clinical improvement and limb perfusion.
Results: No serious adverse events were observed. All cases showed
improvement in symptoms, although this was temporary in some patients.
Conclusion: Selective delivery of bFGF using AGHMs was suggested
to be safe and well-tolerated in patients with PAD.
Increased Metabolic Activity in Abdominal Aortic Aneurysm Detected by
18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/
Computed Tomography (PET/CT)
Kotze C.W., Menezes L.J., Endozo R., Groves A.M., Ell P.J., Yusuf S.W.
Eur J Vasc Endovasc Surg 2009;38:93-99.
Objectives:Abdominal aortic aneurysms (AAAs) are associated with an
inflammatory cell infiltrate and enzymatic degradation of the vessel wall. The
aim of this study was to detect increased metabolic activity in the wall of the
AAA with 18F-fluorodeoxyglucose (18F-FDG), mediated by glucose trans-
porter protein (GLUTs), using a dedicated hybrid PET/64-detector CT.
Design, method and materials: 14 patients (All male, mean age 73.6
years, range 61–82) with AAA under surveillance underwent PET/CT
scanning with 175 MBq of intravenous I8F-FDG. The maximum aneurysm
diameter and calcification score were determined on the attenuation correc-
tion CT. A volume of interest was placed on the aneurysm sac and the
maximum Standardised Uptake Value (SUVmax) measured.
Results: The mean aneurysm diameter was 5.4 cm (SD  0.8). Two
aneurysms had the CT characteristics of inflammatory aneurysms. Twelve
aneurysms showed increased FDG uptake (SUVmax  2.5). There was no
significant difference in FDG uptake between heavily calcified aneurysms
and non-heavily calcified aneurysms (t-test). There was a significant increaseReaders can access EJVES articles at http://intl.eConclusion: The findings in this study offer in vivo evidence that the
AAA wall shows increased glucose metabolism, mediated by the GLUTs:
this increased metabolic activity as detected by PET/CT may be present in
most AAAs.
Endovascular Management of Chronic Disabling Ilio-caval Obstruc-
tive Lesions: Long-Term Results
Hartung O., Loundou A.D., Barthelemy P., Arnoux D., Boufi M., Alimi
Y.S. Eur J Vasc Endovasc Surg 2009;38:118-124.
Objective: To report the long-term results of stenting for chronic
ilio-caval obstructive lesions.
Material and methods: From January 1996 to January 2008, 89
patients (72 women, 17 men; median age 43 years) were admitted for
endovascular treatment of chronic disabling non-malignant obstructive
ilio-caval lesions. Patients were classified as C2 in 15 cases, C3 in 59,
C4 in seven, C5 in two and C6 in six. Median preoperative venous
disability score (VDS) and venous clinical severity score (VCSS) were 2
and 9, respectively. Aetiology was primary in 52 patients, secondary in 35
and congenital in two. Lesions were bilateral in seven cases, eight patients
had inferior vena cava (IVC) involvement and 18 had common femoral
vein (CFV) obstructive lesions. Complete occlusion was found in 30
cases.
Results: Technical success was achieved in 98%. The median hospital
stay was 2 days. During a median follow-up of 38 months (range: 1–144
months), one patient died and five cases of thromboses occurred. Iterative
stenting was performed for restenosis in six cases. Primary, assisted-primary
and secondary patency rates, in terms of intention to treat, were 83%, 89%
and 93%, respectively, at 3 and 10 years, with a median VDS of 1. Univariate
analysis found that significant factors affecting patency were CFV involve-
ment for primary patency and history of deep venous thrombosis (DVT) and
CFV involvement for secondary patency.
The last 46 patients had statistically more severe lesions than the first 43
(higher VDS, more secondary lesions, more occlusions, more stented seg-
ments, higher length of stented vein), and in spite of which patency rates are
not different.
Conclusion: Endovenous angioplasty, combined with stenting, is a
sure, safe, effective and very minimally invasive technique which provides
good long-term patency rates. Currently, it is recognised as the technique ofin the FDG uptake in the two inflammatory aneurysms compared to the
other twelve aneurysms (t-test; P  0.04).
choice for the treatment of ilio-caval obstructive lesions. Surgery should be
proposed only in case of failure.lsevierhealth.com/journals/ejvs/default.cfm
